{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:06:26Z","timestamp":1773291986800,"version":"3.50.1"},"reference-count":28,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,10,29]],"date-time":"2019-10-29T00:00:00Z","timestamp":1572307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal Orthopaedic Research"],"published-print":{"date-parts":[[2020,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>One possible approach to treat osteoarthritis (OA) is to counteract cartilage degeneration with anabolic compounds that stimulate chondrocyte proliferation and\/or extracellular matrix (ECM) production. Several molecules including sprifermin (recombinant human fibroblast growth factor [FGF18]), insulin\u2010like growth factor\u20101 [IGF1] and \u20102 [IGF2], C\u2010type natriuretic peptide [CNP], and bone metamorphic protein 7 [BMP7] have been shown to have these characteristics both in vitro and in vivo. However, it is not known how these molecules compare each other regarding their effect on phenotype and stimulation of ECM production in primary chondrocytes. The effects of sprifermin, IGF1, IGF2, CNP, and BMP7 were evaluated on bovine articular chondrocytes, first in monolayer to determine their effective concentrations, and then in three\u2010dimensional (3D) culture at concentrations of 100\u2009ng\/ml for sprifermin; 300\u2009ng\/ml for IGF1, IGF2, and BMP7; and 10\u2009nM for CNP. In 3D culture, the effects of a permanent exposure or a cyclic exposure consisting of 24\u2009h incubation per week with the compounds were evaluated. All growth factors increased ECM production and cell proliferation to a similar extent but CNP had almost no effect on bovine chondrocytes. Sprifermin was more effective with cyclic exposure, IGF1, and IGF2 with permanent exposure, and BMP7 showed similar results with both exposures. Regarding the cell phenotype, sprifermin appeared to be the only compound favoring the chondrocyte phenotype; it decreased type I collagen expression and had no hypertrophic effect. Together, these results confirmed that sprifermin is a promising disease\u2010modifying OA drug. \u00a9 2019 The Authors. <jats:italic>Journal of Orthopaedic Research<\/jats:italic><jats:sup>\u00ae<\/jats:sup> published by Wiley Periodicals, Inc. on behalf of Orthopaedic Research Society. J Orthop Res 38:653\u2013662, 2020<\/jats:p>","DOI":"10.1002\/jor.24491","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T07:52:57Z","timestamp":1571039577000},"page":"653-662","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effects of Sprifermin, IGF1, IGF2, BMP7, or CNP on Bovine Chondrocytes in Monolayer and 3D Culture"],"prefix":"10.1002","volume":"38","author":[{"given":"Sylvia","family":"M\u00fcller","sequence":"first","affiliation":[{"name":"Osteoarthritis Research, Merck KGaA  Frankfurter Strasse 250 Darmstadt 64293 Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Lindemann","sequence":"additional","affiliation":[{"name":"Osteoarthritis Research, Merck KGaA  Frankfurter Strasse 250 Darmstadt 64293 Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1399-7957","authenticated-orcid":false,"given":"Anne","family":"Gigout","sequence":"additional","affiliation":[{"name":"Osteoarthritis Research, Merck KGaA  Frankfurter Strasse 250 Darmstadt 64293 Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2019,10,29]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"OARSI.2016.Osteoarthritis: a serious disease. Available from:http:\/\/www.oarsi.org\/sites\/default\/files\/docs\/2016\/oarsi_white_paper_oa_serious_disease_121416_1.pdf"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21596"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38614"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2017.08.004"},{"issue":"2","key":"e_1_2_7_6_1","first-page":"80","article-title":"OP0059\u00a0Efficacy and safety of intra\u2010articular sprifermin in symptomatic radiographic knee osteoarthritis: pre\u2010specified analysis of 3\u2010year data from a 5\u2010year randomised, placebo\u2010controlled, phase ii study","volume":"77","author":"Hochberg M","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.2002.63.301"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2006.04.002"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38357"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/gt.2014.58"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.25232"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/08977190802291733"},{"key":"e_1_2_7_13_1","first-page":"103","article-title":"Regulation of anabolic and catabolic gene expression in normal and osteoarthritic adult human articular chondrocytes by osteogenic protein\u20101","volume":"22","author":"Fan Z","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2521"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2474-11-232"},{"key":"e_1_2_7_16_1","unstructured":"Ember Therapeutics.Ember therapeutics announce initial positive results from a phase 2 trial of BMP\u20107 in patients with moderate osteoarthritis of the knee. Available from:http:\/\/embertx.com\/investors.html"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2014.07.018"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1089\/tea.2007.0035"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38199"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-011-1857-3"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1053\/joca.2002.0514"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.MLG.0000175541.31131.A5"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01953688"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/jor.22036"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M302048200"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0885328210388439"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2013.01.009"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.2612"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-018-0123-4"}],"container-title":["Journal of Orthopaedic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jor.24491","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jor.24491","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jor.24491","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T18:38:25Z","timestamp":1694025505000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jor.24491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,29]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["10.1002\/jor.24491"],"URL":"https:\/\/doi.org\/10.1002\/jor.24491","archive":["Portico"],"relation":{},"ISSN":["0736-0266","1554-527X"],"issn-type":[{"value":"0736-0266","type":"print"},{"value":"1554-527X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,29]]},"assertion":[{"value":"2019-07-02","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-10-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}